An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.
O'Donnell C, Mahmoud A, Keane J, Murphy C, White D, Carey S, O'Riordain M, Bennett MW, Brint E, Houston A.
O'Donnell C, et al. Among authors: brint e.
Br J Cancer. 2016 Jan 12;114(1):37-43. doi: 10.1038/bjc.2015.433. Epub 2015 Dec 17.
Br J Cancer. 2016.
PMID: 26679377
Free PMC article.